Bosutinib: a SRC–ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia

Por Rassi, Fuad El, Khoury, Hanna Jean
Publicado em 2013

Updated Product Label Allows Home Administration of Omacetaxine Mepesuccinate

Por Shen, Ann Q., Munteanu, Mihaela, Khoury, Hanna Jean
Publicado no Oncologist (2014)

Bosutinib in the treatment of patients with Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia: an overview

Por Shen, Ann Q., Wilson, Nicole M., Gleason, Shannon L., Khoury, Hanna Jean
Publicado em 2014

Efficacy of dasatinib for the treatment of intractable chronic myeloid leukemia

Por Lima, Lisa M, Arellano, Martha, Holloway, Stacie, Shepard, Marian, McMillan, Stephanie, Khoury, Hanna Jean
Publicado em 2010

Epidermal Growth Factor Stimulates RSK2 Activation through Activation of the MEK/ERK Pathway and Src-dependent Tyrosine Phosphorylation of RSK2 at Tyr-529

Por Kang, Sumin, Dong, Shaozhong, Guo, Ailan, Ruan, Hong, Lonial, Sagar, Khoury, Hanna Jean, Gu, Ting-Lei, Chen, Jing
Publicado em 2007

14–3-3 integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1–transformed hematopoietic cells

Por Dong, Shaozhong, Kang, Sumin, Gu, Ting-Lei, Kardar, Sean, Fu, Haian, Lonial, Sagar, Khoury, Hanna Jean, Khuri, Fadlo, Chen, Jing
Publicado em 2007

The SMAC mimetic RMT5265.2HCL induces apoptosis in EBV AND HTLV-I associated lymphoma cells by inhibiting XIAP and promoting the mitochondrial release of cytochrome C and Smac

Por Ramachandiran, Sampath, Cain, Joan, Liao, Albert, He, Yanjuan, Guo, Xiangxue, Boise, Lawrence H., Fu, Haian, Ratner, Lee, Khoury, Hanna Jean, Bernal-Mizrachi, Leon
Publicado em 2012

FGFR3 Activates RSK2 to Mediate Hematopoietic Transformation through Tyrosine Phosphorylation of RSK2 and Activation of the MEK/ERK Pathway

Por Kang, Sumin, Dong, Shaozhong, Gu, Ting-Lei, Guo, Ailan, Cohen, Michael S., Lonial, Sagar, Khoury, Hanna Jean, Fabbro, Doriano, Gary Gilliland, D., Leif Bergsagel, P., Taunton, Jack, Polakiewicz, Roberto D., Chen, Jing
Publicado em 2007

Potent, transient inhibition of BCR-ABL with dasatinib 100 mg daily achieves rapid and durable cytogenetic responses and high transformation-free survival rates in chronic phase ch...

Por Shah, Neil P., Kim, Dong-Wook, Kantarjian, Hagop, Rousselot, Philippe, Llacer, Pedro Enrique Dorlhiac, Enrico, Alicia, Vela-Ojeda, Jorge, Silver, Richard T., Khoury, Hanna Jean, Müller, Martin C., Lambert, Alexandre, Matloub, Yousif, Hochhaus, Andreas
Publicado em 2010

A Therapeutically Targetable Mechanism of BCR-ABL-Independent Imatinib Resistance in Chronic Myeloid Leukemia

Por Ma, Leyuan, Shan, Yi, Bai, Robert, Xue, Liting, Eide, Christopher A., Ou, Jianhong, Zhu, Lihua J., Hutchinson, Lloyd, Cerny, Jan, Khoury, Hanna Jean, Sheng, Zhi, Druker, Brian J., Li, Shaoguang, Green, Michael R.
Publicado em 2014

A Phase 1 Dose-Escalation Study of ARRY-520, a KSP Inhibitor, in Patients with Advanced Myeloid Leukemias

Por Khoury, Hanna Jean, Garcia-Manero, Guillermo, Borthakur, Gautam, Kadia, Tapan, Foudray, Maria Cielo, Arellano, Martha, Langston, Amelia, Bethelmie-Bryan, Beverly, Rush, Selena, Litwiler, Kevin, Karan, Sharon, Simmons, Heidi, Marcus, Adam I., Ptaszynski, Mieke, Kantarjian, Hagop
Publicado no Cancer (2011)

Reducing the Risk for Transplantation-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?

Por Horan, John T., Logan, Brent R., Agovi-Johnson, Manza-A., Lazarus, Hillard M., Bacigalupo, Andrea A., Ballen, Karen K., Bredeson, Christopher N., Carabasi, Matthew H., Gupta, Vikas, Hale, Gregory A., Khoury, Hanna Jean, Juckett, Mark B., Litzow, Mark R., Martino, Rodrigo, McCarthy, Philip L., Smith, Franklin O., Rizzo, J. Douglas, Pasquini, Marcelo C.
Publicado em 2011

Does FLT3 Mutation Impact Survival after Hematopoietic Cell Transplant for AML? A CIBMTR Analysis

Por Deol, Abhinav, Sengsayadeth, Salyka, Ahn, Kwang Woo, Wang, Hai-Lin, Aljurf, Mahmoud, Antin, Joseph Harry, Battiwalla, Minoo, Bornhauser, Martin, Cahn, Jean-Yves, Camitta, Bruce, Chen, Yi-Bin, Cutler, Corey S., Gale, Robert Peter, Ganguly, Siddhartha, Hamadani, Mehdi, Inamoto, Yoshihiro, Jagasia, Madan, Kamble, Rammurti, Koreth, John, Lazarus, Hillard M., Liesveld, Jane, Litzow, Mark R., Marks, David I., Nishihori, Taiga, Olsson, Richard F., Reshef, Ran, Rowe, Jacob M., Saad, Ayman A., Sabloff, Mitchell, Schouten, Harry C., Shea, Thomas C., Soiffer, Robert J., Uy, Geoffrey L., Waller, Edmond K., Wiernik, Peter H., Wirk, Baldeep, Woolfrey, Ann E., Bunjes, Donald, Devine, Steven, de Lima, Marcos, Sandmaier, Brenda M., Weisdorf, Dan, Khoury, Hanna Jean, Saber, Wael
Publicado no Cancer (2016)